The Production Linked Incentive (PLI) Scheme for Promotion of Domestic Manufacturing of critical Key Starting Materials (KSMs)/ Drug Intermediates and Active Pharmaceutical Ingredients (APIs) in the Country with a financial outlay of Rs. 6,940 crores was approved by the Cabinet to boost domestic manufacturing of bulk drugs in the country, …
Read More »